Approximately 350,000 individuals in the US are affected annually by severe and moderate traumatic brain injuries (TBI) that may result in long-term disability. This rate of injury has produced ~ 3.3 million disabled survivors in the US alone. There is currently no specific treatment available for TBI other than supportive care, but aggressive prehospital resuscitation, rapid triage, and intensive care have reduced mortality rates. With the recent demonstration that neurogenesis occurs in all mammals (including man) throughout adult life, albeit at a low rate, the concept of replacing neurons lost after TBI is now becoming a reality. Experimental rodent models have shown that neurogenesis is accelerated after TBI, especially in juveniles. Two approaches have been followed in these rodent models to test possible therapeutic approaches that could enhance neuronal replacement in humans after TBI. The first has been to define and quantify the phenomenon of de novo hippocampal and cortical neurogenesis after TBI and find ways to enhance this (for example by exogenous trophic factor administration). A second approach has been the transplantation of different types of neural progenitor cells after TBI. In this review the authors discuss some of the processes that follow after acute TBI including the changes in the brain microenvironment and the role of trophic factor dynamics with regard to the effects on endogenous neurogenesis and gliagenesis. The authors also discuss strategies to clinically harness the factors influencing these processes and repair strategies using exogenous neural progenitor cell transplantation. Each strategy is discussed with an emphasis on highlighting the progress and limiting factors relevant to the development of clinical trials of cellular replacement therapy for severe TBI in humans. (DOI: 10.3171/2009. 4.JNS081087) key WoRds • traumatic brain injury • neurogenesis • neural progenitors • cell transplantation
M
any clinical and animal model studies have now shown that severe and even moderate TBI is characterized by both neuronal and white matter loss, with resultant brain atrophy and functional neurological impairment. Injury may be in the form of focal damage, as typically occurs after acute subdural hemotoma, or it may be diffuse, with widespread delayed neuronal loss, as typically occurs after DAI. Despite generally improving rates of survival after TBI, ~ 80,000 individuals in the US annually sustain TBIs that result in significant long-term disability, ranging from vegetative state to memory and behavioral impairment. 90 This has produced about 3.3 million disabled survivors, in the US alone, who are dependent on others and the state for care. In other countries, such as Colombia, Brazil, and China, the prevalence of TBI survivors is up to 5 times higher. 130 Since the demonstration nearly 16 years ago that the mammalian brain has the capacity for self-renewal of neurons and astrocytes, 83 there has been a gradual paradigm shift in neurobiology research such that cell replacement strategies have become a major focus of research and commercial activity. With the confirmation of continual neurogenesis in the adult human hippocampus 20 and subventricular zone, 80, 95 experimental paradigms have expanded to evaluate the response of endogenous NPCs to traumatic injury. The authors of recent Stem cell biology in traumatic brain injury: effects of injury and strategies for repair studies have begun to assess the potential of these cells to generate new neurons capable of functionally counterbalancing neuronal loss in TBI. Based on neuropathological studies in humans and in animal models, it has long been known that astrocyte proliferation after TBI is an early and robust response. 127 More recently, our group and others have shown that de novo hippocampal neurogenesis-"neoneurogenesis"-occurs in response to TBI and is especially robust in juvenile animals. 108 In fact, there is increasing data from multiple areas of the adult mammalian brain to suggest that neurogenesis increases in response to mechanical brain injury and ischemia. 88 Paralleling this new understanding of endogenous neurogenesis, much progress has been made in the area of neuronal transplantation. Human stem cell transplantation trials have now been undertaken for at least 6 indications: Parkinson disease, 24, 53 Huntington disease, 7 spinal cord injury, 69, 81, 125 amyotrophic lateral sclerosis, 13 and syringomyelia. 123 Only for Parkinson disease, however, has clear functional benefit been shown in some patients. Determining the target zone for NPC transplantation for TBI is potentially more complex than for the above indications, due to diffuse cell loss patterns and diverse injury responses, although upregulation of some neurotrophic factors in the injured host environment 73 may favor the survival of transplanted NPCs.
In this review we discuss some of the processes that follow acute TBI, including changes in the brain microenvironment and the role of trophic factor dynamics with regard to effects on endogenous neurogenesis. Strategies for clinically harnessing the factors influencing these processes and repair strategies involving exogenous NPC transplantation are reviewed with the aim of highlighting progress relevant to the potential development of responsible clinical trials for TBI.
Neuronal Loss in TBI
In addition to local neuronal destruction resulting from the mechanical primary insult, TBI also induces a progressive cascade of delayed secondary events that contribute to neuronal death, including ischemia, Wallerian degeneration secondary to diffuse axonal injury, excitotoxicity, dysregulation of calcium homeostasis, mitochondrial dysfunction, and free radical-mediated damage. 78, 92 Despite an improved understanding of these processes, pharmacological neuroprotection trials targeting these secondary mechanisms have failed to improve outcomes in head-injured patients in clinical trials. 112 The patterns of neuronal loss following these events in TBI are both focal and diffuse. Focal damage is typically seen around hemorrhagic lesions, such as contusions within the gray matter or at gray-white junctions. These lesions are typically at the frontal and temporal poles and in the orbital frontal cortex. 26 Such focal neuronal death may occur by both rapid necrotic and slower apoptotic mechanisms. 13, 106 Among diffuse injury sites, the hippocampus is known to be especially vulnerable in humans, with neuronal loss occurring in > 80% of fatal TBI, even in the absence of elevated ICP. 45, 46 It is salient that apoptotic neurons in the process of cell death have been observed in the human hippocampus as long as 12 months postinjury. 121 Following the acute phase of focal TBI and brain ischemic events, hippocampal neurons may be the most vulnerable neurons in the brain, as they show the earliest evidence of TBI-induced degeneration in experimental models. 62 These hippocampal changes correlate with the profound memory impairment seen in both human and animal models of TBI. 105, 114 In the 2 most frequently used experimental TBI models, the LFP and CCI injury models, selective neuronal death has been well described in the hippocampus. 66 The slow, diffuse neuronal loss that is often seen in DAI, involving apoptotic morphological characteristics and Wallerian degeneration, was previously thought to be an inevitable result of axonal interruption as seen in primary axotomy of CNS neurons. More recently, animal studies of DAI have shown that despite the proximity of traumatic axonal injury to the neuronal somata, neuronal cell bodies do not show a pathological progression to cell death, and in fact exhibit changes suggestive of reorganization and potential repair. 103 Thus, injured neurons may be amenable to rescue by endogenous therapeutic interventions. Such interventions must take into account the changes in the injury microenvironment that are both favorable and unfavorable to regenerative efforts.
The Injury Microenvironment
The brain activates a dramatic response to traumatic injury, which initially manifests as changes in the cellular microenvironment. These changes involve inflammation, disruption of physical structure and protein expression in the extracellular matrix, and altered trophic factor expression. It is possible that while some of these mechanisms attenuate acute damage at the expense of future regenerative capacity, others retain the potential to participate in therapeutic interventions.
Inflammatory Mechanisms and Gliosis
The CNS is no longer regarded strictly as an "immunologically privileged site" with limited access of antibodies and inflammatory mediators through the blood-brain barrier. Traumatic brain injury is a neuroinflammatory condition of the CNS, in which rupture of the blood-brain barrier leads to accumulation of leukocytes from the systemic circulation and subsequent initiation of the immune functions of native glia. 67 Acute inflammatory cytokinemediated events, such as monocyte/macrophage-mediated phagocytosis, 35 and complement-mediated cytolysis 107 are now well recognized to begin early after TBI and persist several days or weeks. This response is partially represented in the form of "microglial stars" and "perivascular cuffing" in human pathological specimens.
1 Transplanted cells may be less likely to survive in this hostile environment immediately after TBI. 64 Both inflammatory mechanisms and necrotic cell death trigger reactive gliosis, the astrocytic response to injury, which is seen as astrocyte hypertrophy, fibrillary process activation, and penumbral proliferation. 102 Glial fibrillary acidic protein staining increases dramatically in tissue samples from many areas of the brain days, weeks, and months after severe TBI. 127 Concomitant deposition of extracellular matrix molecules distorts the architecture of the neuropil, which has long been known to produce mechanical obstruction of axon regeneration. On the other hand, increased laminin and fibronectin deposition may favor repair, 110 while matrix metalloproteinases are active in regulating reactive synaptogenesis. 21 Recently, it has become clear that the production of inhibitory molecules such as proteoglycans are equally as important in creating a nonpermissive environment for axons attempting to regenerate. 23 Nogo-A, myelin-associated protein, and oligodendroctye myelin are CNS myelin-associated molecule inhibitors of axonal regeneration that have been studied extensively in vitro, although their in vivo roles have not been well characterized. 29 In TBI models Nogo-A is known to be upregulated after fluid percussion, 61 and intraventricular infusion of an anti-Nogo antibody has been associated with improved postinjury cognitive recovery. 49, 60 Such strategies to retard the molecular and structural inhibition of axonal regeneration may be necessary to allow integration of axons from newborn neurons introduced therapeutically to the injured brain.
Dysmyelination After TBI
Very little is known about the role of abnormal myelination after TBI, in contrast to SCI, in which it has been shown to affect 20-30% of axons that appear to be in continuity. 128 The results of ultrastructural studies have shown poorly myelinated axons and disorganization of myelin layers after TBI, but quantization studies are lacking. 128 If dysmyelination is important in TBI, then oligodendroctye progenitor cell transplantation or endogenous activation strategies may eventually be worthy of therapeutic trials. Cografting NPCs with olfactory ensheathing cells, which guide olfactory receptor axons to the olfactory bulb, has also been proposed. 5 This follows the great surge of interest in transplanting olfactory ensheathing cells in SCI, 33 which has occurred in a Phase I clinical trial. 22 
Neurotrophic Factor Dynamics
The authors of several studies have shown that neurotrophic factor expression is significantly altered after experimental TBI. Ribonucleic acid studies have shown that some neurotrophic compounds such as NGF and BDNF are upregulated, 73, 113 while others, such as NT-3, are downregulated. 31, 124 Data from the cortical contusion model suggest that FGF-2 is also unregulated, which stimulates posttraumatic neurogenesis and preserves granule cell layer volume, effects that are increased with FGF-2 supplementation via gene transfer.
126 S100B is a neurotrophic and neuroprotective calcium-binding protein produced primarily by astrocytes that, despite a correlation between increased CSF levels and poor prognosis in patients with TBI, has been shown to have a beneficial effect on neuronal maintenance, neurogenesis, and cognitive performance in rodent TBI models (see review by Kleindienst and Bullock 41 ). These alterations are not a simple issue of up versus downregulation, however, as they occur with temporal, subregion, and age-related specificity. As a point of illustration, BDNF levels after experimental TBI are increased to a greater extent in older rather than in younger animals, 99 despite the wellknown fact that older age is correlated with a worse outcome after TBI.
Clearly, the differential interaction among multiple neurotrophins, many of which remain unrecognized, is important in determining the final number and phenotype of new neurons generated in different brain regions after TBI, and would affect the differentiation and integration of cells transplanted into the injury microenvironment ( Fig. 1) .
Endogenous Neurogenesis After TBI
The most well-characterized neurogenic region in the adult human brain is the SVZ lining the lateral ventricle, where a ribbon of SVZ astrocytes have been identified that proliferate in vivo and behave as multipotent progenitor cells in vitro. 95 Unlike in rodents and primates, where neurons born in the SVZ migrate in chains through the rostral migratory stream to replace interneurons of the olfactory bulb, 3, 44, 75 currently there is no evidence for chains of migrating neuroblasts in the human SVZ. 80, 94 It has been estimated that in normal humans, < 1% of astrocytes within the SVZ ribbon are undergoing cell division, 95 and although these endogenous NSCs can be expanded in culture, 117 their response to injury in patients has not been studied. Less well-characterized in the human brain are proliferating NPCs in the hippocampus, 20 which have also been demonstrated as multipotent progenitor cells in vitro. 91 Rat models have been used to investigate TBI-induced neurogenesis and have shown that the number of NPCs in both the SVZ and hippocampus is substantially increased after TBI, a process that is more robust in juvenile animals. Newborn NPCs from the SVZ appear to have the potential to migrate to areas of focal cortical damage, while hippocampal neurogenesis occurs in the setting of diffuse local damage. Nevertheless, in adult and aged animals, the number of new neurons developing after TBI remains small in comparison with astrocyte and oligodendroctye differentiation, as assessed by BrdU staining.
Subventricular Zone Neurogenesis After Trauma
In common with models of seizure, ischemia, and deafferentation injury, experimental TBI induces an increase in SVZ proliferation, and a secondary redirected streaming of these precursors into the injured zone. 74 Fluid percussion injury studies in our labs have demonstrated an up to 2-fold increase in ipsilateral SVZ proliferation within the first 2-5 days after TBI. 12, 40, 84, 115 Others have reported a 4-fold increase following the more focal CCI, up to 14 days after injury. 55, 82 Contralateral SVZ proliferation also increases, apparently to a lesser extent, after injury in both models. 12, 55, 115 Newborn cells colabeled with BrdU and neuronal phenotypic markers have been observed in the cortex, striatum, and corpus callosum following injury. These markers, such as NeuN, calbindin, and beta-tubulin, provide evidence of mature neuronal cytoplasmic and nuclear features, as much as 45 days after injury. Seminal patch clamping studies have demonstrated that such BrdU-positive cells do in fact exhibit neuronal electrophysiological properties, 129 and moreover, our group and others have shown host tissue anatomical integration of these new neurons by means of retrograde tracer labeling and synaptophysin triple label immunohistochemical techniques.
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Migration of SVZ NPCs to the Site of Injury
Glial cell proliferation has long been appreciated at sites of focal TBI damage, but more recently, it has been shown that some glia migrate into the lesion site from the SVZ, and that these cells arise from NPCs. Intraventricular injection of fluorescent microspheres was recently used to label BrdU-positive subventricular cells, whose migration was then tracked from the SVZ to the cortex surrounding a cortical impact contusion site. 82 In the SVZ, corpus callosum, striatum, and cortex, many of these cells were also positive for doublecortin, a marker of immature neuroblasts, suggesting that local neurogenesis could be driven by injury-specific extracellular signaling pathways. In the pericontusional cortex, expression of the mature neuronal marker NeuN was seen in cells tagged prior to injury by intraventricular infusion of a lipophilic dye, suggesting that these cells were derived from SVZ NPCs that migrated to the site of injury. 93 Whether neuroblasts that migrate from the SVZ can replace cortical neuronal loss caused by TBI remains to be determined. Similarly, it is conceivable that migrating NPCs could be directed toward an oligodendrocyte fate to aid in remyelination of white matter regions damaged by TBI. The potential for directing the phenotypic differentiation of endogenous NPCs that have been clearly shown to migrate to areas of injury, may become an intriguing therapeutic goal, once the molecular cues driving these phenomena are better understood.
Hippocampal Neurogenesis After Brain Trauma
Although selectively more vulnerable to TBI, the neurogenic zones of the hippocampus may have a unique ability to locally replace damaged neurons, as this injury site is normally an area of active endogenous neurogenesis. In humans, in vivo DG neurogenesis was demonstrated on histological sections obtained in patients who had died of cancer, but for which BrdU staining was used for diagnostic purposes. 20 Studies in rodents also demonstrated that cells with an astrocyte phenotype residing in the adult subgranular zone of the DG continually generate cells with a neuroblast phenotype, which migrate into the granule cell layer. 98 Although some of these new neurons die by apoptosis over a few weeks, many demonstrate functional integration within the hippocampal circuitry by sending dendrites into the molecular layer and axons into the CA3 region, 28, 59 and additionally exhibit mature neuronal electrophysiological characteristics. 116 Severe TBI is always associated with learning and memory deficits-the functional hallmarks of TBI. This is usually associated with histological damages in the form of cell loss, especially in the DG and CA1 layers. Because neurogenesis in this region has been linked to enhanced learning and memory function, 50 there is grounds to hypothesize that injury-induced neurogenesis could function to replace damaged neurons, and thus contribute to neuronal circuit repair and restoration of neurological function in patients with TBI. To explore this concept further, we have begun to study the effects of experimental TBI on hippocampal neurogenesis in rodents.
Following both LFP and CCI, cell proliferation increases in the DG. We have shown that proliferation increases 3-to 4-fold beginning as early as 2 days postinjury and peaks during the first week after injury, and we have observed a return to baseline levels of proliferation in the DG by Day 35 postinjury. 84, 108 Similarly, other groups have detected an up to 6-fold increase in dividing cells in the ipsilateral DG and a significant but lesser increase in the contralateral DG. 14, 19, 38, 55, 126 What is especially important in the hippocampus, however, is that a significant increase in the number of new cells that express neuronal markers has been reported after longer maturation periods, suggesting that injury-induced proliferation may be more strongly neurogenic in the DG than that which results mainly in astrocytic proliferation, as seen in the cortical injury zone. Our group has reported a TBI-induced 4-fold increase in the number of BrdUlabeled cells that colabel for NeuN, a mature neuronal phenotypic marker, at 5 days after injury. By 10 weeks after injury, however, these BrdU-labeled neurons had migrated to the inner half of the granular cell layer, where ~ 46% of those seen at 5 days were still present. 109 Other authors have reported a 5-fold increase in the number of injury-generated double-labeled neurons, seen as late as 60 days postinjury. 38 The central issue remains, however: do these new neurons functionally integrate with the host hippocampal tissue and exhibit appropriate electrophysiological characteristics?
To begin to answer these questions, we have found that BrdU-labeled neurons in the hippocampus, born following injury, express NeuN and calbindin, indicative of a mature neuronal dentate phenotype. 109 Moreover, we performed stereotactic retrograde tracer injections of the neuronal tracer florogold into the CA3 region, which is one target zone for the granular cell neurons projections. After 2 weeks, about 30% of the BrdU-positive cells in the DG were labeled with florogold, suggesting connectivity with the CA3 target region. Notably, there were 4 times more double-labeled florogold/BrdU cells in the TBI group than in sham controls. To further investigate the functional connectivity of these cells, these sections were also stained with synaptophysin, a marker of synaptic vesicle membrane proteins. Florogold/BrdU-labeled cell bodies were frequently enveloped by a synaptophysin lattice, as previously described, 59 suggesting the for mation of synapses onto the soma of newborn neurons (Fig. 2) .
In terms of measuring whether posttraumatic neurogenesis is functional on a broader scale that affects behavior, several authors have shown reduced behavioral and memory function as assessed in Morris Water Maze tasks, in association with procedures to abolish proliferation of new cells, such as by antimitotic drug administration. 63 We have used low-dose irradiation to markedly reduce neurogenesis in sham and brain-injured rodents, which results in a markedly reduced ability to recover from TBI in terms of spatial memory. Most recently, the inactivation of a subset of adult hippocampal NSCs in mice was shown to produce both a significant reduction in stem cell proliferation and a selective decrement in spatial learning. 127 
Cortical Neurogenesis Following Brain Trauma
Although the hippocampus is selectively damaged in TBI, the greatest density of neuronal loss occurs in focal parenchymal contusions arising in locations that vary with the mechanism of primary or secondary injury (Fig. 3) . As discussed earlier, the injured brain may induce migration of neuroblasts from the SVZ into cortical lesions, but latent NPCs may also be activated at sites of cortical injury in the mammalian brain. In songbirds such as zebra finches, it has long been known that some cortical projection neurons are lost and regenerated each year from SVZ precursors in response to evolutionary pressures to change the quality of song in the male bird. 2 Magavi et al. 56 have suggested the possibility that endogenous neural precursors from the cortex itself, in rodents, may differentiate into corticothalamic neurons in layer VI of the anterior cortex following targeted neuronal death, and survive for many months to form appropriate long-distance corticothalamic connections. In humans, the existence of such NPCs in nongerminal cortex has been suggested from some isolation and culture studies. We have reported the isolation and continuous culture of putative neuroblasts from neocortical tissue, resected in patients with TBIs during decompressive craniotomy for elevated ICP. 87 Others have also previously reported the isolation of neurosphere-generating cells from similar cortical tissue (Fig. 4) . 6 After CCI in rodents, the formation of neurospheres from neocortical cells has also been observed, but only when injured tissue was isolated at 3 days postinjury, corresponding to a peak in nestin expression in pericontusional cortex. 34 Induction of nestin expression in the cortex adjacent to the CCI injury has also been reported at 7 days postinjury, 38 suggesting the possible activation of resident cortical NPCs, although these cells alternatively could have migrated from the SVZ.
Animal Models of TBI
Several attempts have been made to mimic the range of severity of human TBI. Injury models in rodents that produce brain trauma over a wide spectrum of severity and can be modified by adjusting the mechanical parameters of the injury device have been developed. 48 The authors of a number of studies have shown a close relationship between the severity of injury and the posttraumatic response and rate of recovery of brain-injured animals. 62, 77 As a result, a classification for severity of experimental TBI has been developed and established to resemble that of the clinical categories of mild, moderate, and severe TBI. Because the clinical setting is not similar to the laboratory conditions, different injury models are routinely used to produce the main characteristics seen in human TBI, including focal and/or diffuse damage.
Focal models of TBI include: 1) the weight drop model; 2) CCI injury; 3) midline FPI; and 4) optic nerve stretch injury model. Diffuse brain injury models include: 1) the impact acceleration model; and 2) inertial accelera-tion brain injury model. Finally, the lateral FPI model is a mixed model of focal and diffuse brain injury.
Posttraumatic neurogenesis has so far been studied only in rodent models. A recently developed swine CCI model would be useful for validation in a more clinically relevant paradigm. 58 
Therapeutic Strategies
Enhancing Neoneurogenesis Following Brain Trauma
Assuming the adult human brain is capable of generating new neurons in response to injury, as is clearly the case in rodents, what steps could be taken to clinically enhance the production and functional integration of these cells? First, the magnitude of the neurogenic response to injury appears small, and it remains unclear to what extent this is, because new neurons fail to develop at a sufficiently rapid rate versus cell death prior to sufficient integration into the host environment. Clearly, more studies are needed to resolve this question. Many of the various overlapping local interactions between growth factors, extracellular proteins, metalloproteases, neurotransmitters, hormones, and angiogenesis, which define the neurogenic niches of the adult brain, 4 are altered after TBI. Understanding the effects of the disease process on these factors is necessary for developing strategies to influence adult neurogenesis for therapeutic purposes. 51 
Age and Enriched Environment
Juvenile mammals recover cerebral function to a greater extent than adults after TBI. Because cell proliferation in the DG decreases with age in normal rats, 47 we previously hypothesized that age-related differences in hippocampal neurogenesis after TBI may be responsible, in part, for the greater cognitive recovery seen in young mammals. 108 Juvenile rats generated nearly twice the number of new cells in the subgranular zone than adults in the first 2 days after LFP injury (Fig. 5) , although this response appeared to be related to a greater level of basal juvenile neurogenesis, because the percentage increases in cell numbers above baseline were similar in young and old animals. More of the newly born cells differentiated into mature neurons over time in juveniles, as shown by NeuN labeling. Similar new granule cell neurons have been shown to functionally integrate by 14 days after birth 28 and become critically involved in the learning response within this same time period. 101 The combination of these findings suggests that results demonstrating fewer cognitive deficits and better recovery during the first 2 weeks after injury in juvenile rats 79 may result in part from the greater ability of younger animals to generate new hippocampal granule cell neurons in response to injury. The mechanism by which neuronal differentiation is enhanced in younger animals is not entirely clear, but answers to this question may aid discovery of therapeutic interventions to optimize neurogenesis after injury.
Despite a constant decline in NPC proliferation in the DG from adolescence through senescence, 15, 30, 47 the adult brain upregulates proliferation to almost the same extent as the juvenile brain after TBI, indicating that NPCs conserve the ability to respond to proliferative signals. Thus, although injury signals increase the proliferative rate of NPCs, the additional increased presence of newly generated neurons in younger brains may reflect greater integrity of mechanisms in the neurogenic niche, which promote the differentiation or survival of new neurons. One possible means, similar to that hypothesized for the effects of enriched environment on hippocampal neurogenesis (a survival-promoting effect of newborn cells that is selective for neurons 36 ) , is a greater level of specific neurotrophin support 72 that is either not present or not induced in adults.
Neurotrophic Support
It remains unclear whether TBI-induced neurogenesis contributes at all to functional recovery, or whether recovery is the result of other processes such as sprouting, dendritic arborization, or functional synaptic plasticity. To begin to clarify this question, our group has administered FGF and EGF via an osmotic minipump into the lateral ventricle after FPI. This test resulted in an increased rate of memory recovery in the Morris Water Maze, and concomitant increases in the numbers of new hippocampal neurons colabeled with BrdU and NeuN. Similarly, intraventricular administration of S100B, a neurotrophic calcium-binding protein secreted by astrocytes, was also performed. 39, 40 Following TBI and S100B treatment, the percentage of newly generated cells coexpressing NeuN in the DG was increased 2-fold compared with vehicle infusion at 35 days postinjury. These same animals underwent water maze testing on Days 30-34 postinjury. When individual average water maze performance was compared with the percentage of BrdU-NeuN colabeled cells, improved cognitive recovery correlated strongly with the number of newly generated neurons. Lu et al. 54 have evaluated cognitive recovery in animals receiving other neurotrophic factors after CCI. Animals that received erythropoietin for 14 days postinjury had a significantly increased percentage of newly generated cells that differentiated into mature neurons in the granular cell layers of both the contralateral and ipsilateral DG. These animals also performed significantly better than nontreated injured animals in water maze testing.
Additional factors in the neurogenic niche, such as noggin, bone morphogenic proteins, shh, Notch, TGFα, Eph/ephrins, and VEGF, 4 have been less well studied in brain injury models. Upregulation of VEGF is observed after CCI 104 and has been implicated in neurogenesis and neuromigration in a rodent model of focal cerebral ischemia. 118 With a better understanding of the developmental signaling molecules and morphogens mentioned above, mobilizing endogenous NSCs or NPCs for glial or neural repair may become possible via targeted infusion, expression, or silencing of certain niche factors. 52 If the rate of neoneurogenesis is a limiting factor for cognitive recovery, could neurotrophin administration be used clinically in TBI? Although the optimal combinations of neurotrophins remain unknown in rodents, our studies with single mitogens would support this strategy. 42 If prevention of apoptotic cell death over the weeks and months that follow TBI is required, then more classic neuroprotective drug strategies may be needed. For example, experimental neuroinflammation has been shown to inhibit hippocampal neurogenesis, an effect that can be reversed with the administration of minocycline, 18 which inhibits microglial activation and reduces apoptotic cell loss. Additionally, indomethacin, a common nonsteroidal antiinflammatory drug, blocks the effects of endotoxin- and irradiation-induced inflammation on hippocampal neurogenesis. 65 Moreover, the recent clear failure of highdose corticosteroid treatment in TBI 17 could be due in part to this suppressant effect on neurogenesis.
Other Factors
Even if enhanced neoneurogenesis can be achieved, there are still significant impediments to achieving functional reconnection of neuronal circuitry, such as glial scar formation and inflammation, as discussed above. Strategies designed to enhance neurogenesis must also take into account the need to reduce gliosis and enhance growth cone sprouting and synaptogenesis. Elements of intensive physical and occupational therapy, the mainstay of long-term therapy in patients with TBI, such as environmental enrichment, physical exercise, or formal training, have been shown in rodents to enhance many of these processes. 120 Recently, neuroblast migration in the rodent brain was shown to be influenced by CSF flow, which is required for neuroblast orientation and formation in the SVZ. 96 The possible role of CSF in creating neurotrophin flow gradients in the underlying brain parenchyma is especially intriguing, considering the extent to which this flow may be altered after TBI, secondary to increased ICP and hydrocephalus, especially in the SVZ.
Cell Transplantation for Brain Trauma
Clinical trials undertaken so far with cell transplantation for Parkinson disease and Huntington disease have all involved the use of primary fetal tissue containing NSCs and NPCs, for which there was abundant preclinical work in primates, extensively reviewed in the literature. 16, 37 These clinical studies have shown that human fetal mesencephalic dopaminergic neurons can reinnervate the striatum, release dopamine, and integrate in the brain in a manner that induces symptomatic relief. 10, 53 Clinical outcomes have been variable, however, with neither study meeting its primary outcome goal, and graft-induced dyskinesias unexpectedly occurring in a significant number of patients. 24, 27, 71 Future cell transplantation trials will probably use expanded NSCs (rather than primary fetal cells) as graft material. The ability to extensively characterize, modify, and standardize NSCs should allow greater therapeutic predictability after transplantation of these cells. The only such cells to be transplanted in patients are hNT neurons, which are terminally differentiated, postmitotic, nontumorigenic neurons derived from a human teratocarcinoma cell line (NTera-2). Partial recovery of neurological function was reported in some patients who received the transplants. 42, 43 It is important to note, however, that unlike cell grafting to the striatum for Parkinson disease, one of the putative targets for TBI, the hippocampus, is a neurogenic niche 4, 52 and is therefore more likely to permit survival and appropriate differentiation of transplanted NPCs. On the other hand, trauma-related factors that alter the integration of adult newborn neurons into the hippocampal circuitry will also be relevant to the integration of transplanted NPCs. In contrast, focally damaged areas of the neocortex offer a less welcoming milieu for the survival of transplanted neuronal cells. Strategies for clinical transplantation in TBI will likely vary depending on patients' individual anatomical pathology. Graft location will also be tied to the desired functional role of grafted cells. Replacement neurons, remyelinating oligodendrocytes, or supporting chaperone cells are all potentially useful cell types, whose relative value may change based on the clinical situation. The source and characteristics of the various cell types available for transplantation have been well reviewed previously 86, 97 thus, the following discussion will focus on the most recent and clinically applicable cell transplantation data from TBI models.
Neural Progenitor Cell Grafts in TBI Models
In the earliest nontissue cell transplantation studies in TBI, hNT cells were grafted to the periinjured cortex of fluid percussion-injured animals. 68, 76 Despite the survival of transplanted cells in the traumatically injured brain, the hNT cells had no significant effect on posttraumatic neurological, motor, or cognitive function. More recently, hNT neurons transduced to overexpress NGF were transplanted to the medial septal nuclei 24 hours after CCI; this resulted in improved water maze performance at 4 weeks postinjury, 119 but only in animals with NGFsecreting grafts. These results illustrate that hNT neurons have not shown the ability for neuronal integration after TBI, but do function as support cells, proposed to occur via trophic actions of NGF on medial septal neurons and preservation of the septohippocampal pathway. 119 Neural progenitor cell transplantation studies have also demonstrated behavioral improvements in injured animals despite a lack of neuronal differentiation. Shear et al. 100 assessed the long-term survival, migration, differentiation, and functional significance of fetal-derived NPCs transplanted into the ipsilateral striatum of CCItreated mice, out to 1 year posttransplantation. Neural progenitor cells were observed to migrate throughout the injured hippocampus and adjacent cortical regions, but the majority of transplanted cells expressed NG2, an oligodendrocyte progenitor cell marker, while none expressed neuronal markers. Transplanted animals did show significant improvements in spatial learning, suggesting a release of neurotrophic factors by the transplanted cells. Grafted cells also appeared to respond to intrinsic cues by migrating to the ipsilateral hippocampus, an effect that had previously been noted to increase when cells where implanted within a fibronectin matrix.
111 Enhanced migration has also been reported via EGF receptor transduction of immortalized fetal-derived NSCs (C17.2), although these cells too resulted in behavioral improvement despite a lack of neuronal differentiation when transplanted into the corpus callosum of CCI animals. 11 Without EGF receptor transduction, fetal-derived NSCs do express NeuN (a marker of mature neurons) up to 13 weeks after transplantation into animals that showed significantly improved motor function, while cognitive dysfunction was unaffected. 89 Alternately, improved cognition was observed when transplanted C17.2 cells had been transduced with GDNF, which showed an increased migration from the injury periphery. 8 Improvement of sensorimotor, but not cognitive, function has also been observed after transplantation of fetal-derived NPCs to the periphery of the injured cortex in CCI-injured mice, where cells also showed phenotypic evidence of neuronal differentiation. 32 Taken together, these data suggest that separate processes exist for restoring cognitive and motor function, with cognitive recovery associated with the proximity of cells or growth factors to the hippocampus, and motor recovery with cells capable of neuronal differentiation near the site of cortical injury.
The studies discussed above involved the transplantation of undifferentiated cells, with a wait-and-see approach to determine if the injury microenvironment would guide appropriate phenotypic differentiation. The results illustrated the complexity of hypothesizing which cell type would be optimal, and few studies have involved the transplantation of specific neuronal subtypes in TBI models. Murine embryonic stem cells that were predifferentiated into GABAergic neurons produced motor recovery up to 5 weeks postgrafting when transplanted below the cortical injury cavity, while cells predifferentiated to astrocytes did not provide any benefit. 9 However, whether these cells released significant amounts of GABA, or perhaps a neurotrophin, was not investigated. Other authors have transplanted human fetal-derived NSCs, primed to differentiate into cholinergic neurons into the hippocampus of immunosuppressed fluid percussion-injured rats, 25 and found improvements in water maze performance. Transplanted cells expressed the neuronal marker MAP2, and although markers of specific neuronal phenotypes were not assayed, the release of GDNF by grafted cells was suggested by immunohistochemical characteristics and increased detection of GDNF in microdialysis samples.
Possibility of Autologous NSC Transplantation
Because of immunosupression, allogenicity, availability, and possibly neoplasia issues related to NSCs from other sources, autologous NPCs would be an attractive source of cells for first attempts to repopulate the injured brain at the site of focal damage or within the hippocampus. To practically achieve this feat, NPCs must be concentrated from the source tissue, enriched or purified, expanded ex vivo and directed toward a desired lineage. For human use, this must be achieved at a good laboratory practices standard, and the product shown to be safe for transplantation. As proof of concept, we isolated adult rat SVZ NPCs, expanded their number in culture, and transplanted these cells into the adult hippocampus to test their ability to transdifferentiate into neurons appropriate to the hippocampal niche. By 2 weeks after transplantation, nearly 80% of cells that were located in the granule cell layer had the immunohistochemical profile of granule cell neurons, suggesting the ability of adult SVZ cells to transdifferentiate into locally appropriate neurons in the hippocampus. 85 In more recent studies by our group and others, human neurosphere-derived NPCs have been transplanted into fluid percussion-injured Fischer 344 rats, with immunosuppression (Fig. 6) . Both increased graft cell proliferation and more robust incorporation into the host hippocampus was seen after TBI in injured than in noninjured animals that received transplants. Autologous transplantation of tissue containing putative NPCs harvested from contusion zones and reintroduced into patients with TBI has also been reported from China.
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Transplantation for Remyelination
Oligodendrocyte progenitors have been isolated from the adult white matter 70 and have been reported to remyelinate demyelinating lesions in the adult rat brain. 122 
Potential Adverse Effects of Enhancing Neurogenesis
Neoplastic transformation of transplanted cells, especially if they are genetically transformed or of pluripotential lineage, has been a theoretical concern in the planning of neural transplant studies, and underscores the attractions of endogenous stem cell enhancement strategies. Ensuring that the cells are fully committed to neuronal differentiation at the time of transplantation may be important. The need for immunosupression, possibly lifelong, is also a major clinical concern for allograft transplantation strategies. The possibility of induction of an epileptic focus at the transplant site secondary to dysfunctional integration must also be considered. Unwanted neurological functions, such as enhancement of pain, or even limbic behavioral changes, could possibly follow hippocampal transplantation.
Future Directions
Massive advances in the understanding of endogenous stem cell and transplanted NPC biology have come from availability of mitotic reporters, such as BrdU staining or H 3 -thymidine labeling and retroviral green fluorescent protein transduction. Such methods cannot be used easily in vivo in humans so surrogate reporter methods are required. These methods could include MR imaging morphometry, which allows measurement of the cortical ribbon thickness, or hippocampal volume, for example. Paramagnetic contrast agents for MR imaging that could be incorporated into grafted cells, such as lipid micelles, have been considered. Recently, a biomarker of NPCs that can be detected on MR spectroscopy has been reported. 57 
Conclusions
With the new paradigm of endogenous neurogenesis and directed differentiation of transplanted NPCs comes the promise of hitherto unimagined therapeutic potential in destructive diseases of the CNS such as TBI and SCI. It is our responsibility to bring this potential to fruition as rapidly as possible, but we bear an even greater responsibility to evaluate such therapies fully and understand their utility and potential dangers before we offer them to our patients, who are vulnerable to the sometimes extravagant claims made frequently in the lay media in this rapidly changing field.
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This work was funded by National Institute of Neurological Disorders and Stroke (NINDS 1RO1 NS055086-01A2). Fig. 6 . Photomicrographs of human NPCs derived from neurospheres, stained with BrdU, grown from TBI tissue debris, resected at surgery for elevated ICP, and transplanted into the hippocampal region of Fischer 344 rats. Sample from a noninjured host rat is shown in panel A and a host rat 7 days after TBI in panel B.
